Bimekizumab Efficacy by Prior Biologic Treatment in Patients With Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials. J of Skin 2024, 8 (1), s349. https://doi.org/10.25251/skin.8.supp.349.